[Investigation, treatment and monitoring of late-onset hypogonadism in males: the official guidelines of the International Society for the Study of the Study of the Aging Male (ISSAM) with comments].
There is increasing interest in the subject of hormone changes in the aging male, which is likely to become particularly important with the expected growth in the population of men over 50. The main concerns at present are androgen decline in the aging male (ADAM), or partial androgen deficiency of the aging male (PADAM), commonly known as the andropause. Although there have been advances in our knowledge of androgen deficiency in the aging male, it is still incomplete, sometimes confusing, and some aspects of androgen replacement therapy remain controversial. The International Society for the Study of the Aging Male (ISSAM) therefore felt it was a good time to review the current situation by publishing a series of practical and official guidelines concerning the diagnosis, treatment and monitoring of late-onset hypogonadism in males. The aim of this study is to present the French translation of these recent international guidelines, and to comment on them.
Service d'Urologie, Hôpital Edouard Herriot, Lyon, France.
B
B
Cuzin
F
F
Giuliano
Ch
Ch
Jamin
J-J
JJ
Legros
H
H
Lejeune
J-M
JM
Rigot
M
M
Roger
D000375:Aging; D000728:Androgens / Q000172:deficiency; D003687:Dehydroepiandrosterone / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005602:France; D006728:Hormones / Q000097:blood*; D019382:Human Growth Hormone / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007006:Hypogonadism / Q000097:blood / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy; D007802:Language; D008297:Male; D008550:Melatonin / Q000097:blood; D017410:Practice Guidelines as Topic; D011795:Surveys and Questionnaires
D000728:Androgens; D006728:Hormones; D019382:Human Growth Hormone; D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate; D008550:Melatonin